Clinical Trial Search

Primary: Efficacy of Tattoo Removal Using Topical Imiquimod 5% Cream — 4.3; 2.7 percentage of tattoo pigment removed

Primary: Tattoo Clearing as Rated by Blinded Evaluator — 21 Participants

Primary: Tattoo Clearing at 6 Weeks Post-final Laser Treatment for Each Treatment Arm as Assessed by Blinded Reviewers. — 2.54; 2.17 score on a scale

Primary: Tattoo Clearing as Rated by Investigator — 4 score on a scale

Primary: Tattoo Clearance — 2.875; 4.25 score on a scale — p=.0077

Primary: Tattoo Clearance — 2.5; 3.0 score on a scale

Primary: Degree of Tattoo Clearing as Assessed by the Investigator (Physician's Global Assessment of Improvement) — 4; 4; 4 score on a scale

Primary: Degree of Tattoo Clearing at 6 Weeks Post-final Treatment as Assessed by the Investigator — 2 score on a scale

Primary: Tattoo Clearance Using Photographic Evaluation — 15; 6; 2 Tattoos

Primary: Number of Patients With Tattoo Clearance — 3; 5 Participants

Primary: Level of Tattoo Clearing at 12 Weeks for Each Treatment Arm as Assessed by the Blinded Reviewers. — 3; 3 score on a scale

Primary: Tattoo Clearance Percentage Using a Photographic Scale — 84.7 percentage of clearance

Primary: Median VAS Improvement Score as Assessed by Blinded Physician Reviewers — 1.5 units on a scale — p=<0.0001

Primary: Photographic Evaluation of Scar Clearance — 1.82 score on a scale

Primary: Percentage of Participants With Change of Treated Lesions — 44; 44; 13 % of participants

Primary: Change in Wrinkles From Baseline to 12 Weeks Post-study Treatment Assessed by Blinded Photographic Evaluation Using 9-Point Fitzpatrick Wrinkle Scale

Primary: This is a Study to Measure the Efficacy of the Nd:YAG Laser to Cause Complete Regression of Basal Cell Carcinoma. — 28 tumors

Primary: Changes in Facial Scarring Score — -.50 score on a scale

Primary: Change in Hair Growth — 57.6; 52.1; 39.3; 29.9 % hair reduction — p=0.2879

Primary: Photographic Evaluation of Striae Clearance — 36; 17; 11 areas with striation

Primary: Clearance Based on Photographic Scale — 2; 2; 4; 7 Participants

Primary: Degree of Improvement in Erythematotelangiectatic Rosacea and Papulopustular Rosacea — 2.114; 2.088 score on a scale

Primary: Acne Scarring Improvement — 4; 4 score on a scale

Primary: Comparison of Percent Hair Reduction Between Treatment Arm and Non-treated Control Arm at 12 Weeks Post Final Treatment — 41; 27 percent reduction

Primary: Change in Spots - Front of Face (Part 1) — 53.60; 58.47; 56.44 spots

Primary: Change in Dyspigmentation Spots — 48.3; 46; 42.2; 42.5 Dyspigmentation Spots

Primary: Change From Baseline in a* and E at 8 Weeks — 1.27; 0.43; 4.08; 2.59 units on a scale

Primary: Mean Changes in Color, Texture, and Size of Cherry Angiomata From Baseline to 3 Months After the Second Treatment by Treatment Type as Assessed by Blinded Raters — 5.27…

Primary: Reduction in Hair Count in the Treated Area — 13.1; 10.7; 18.7 percentage of hair reduction

Primary: Photographic Evaluation Using the Blinded Global Aesthetic Improvement Scale — 0; 1; 3; 3 Participants